tirzepatide causing pancreatitis Suspected drug-induced was rare but more common in patients taking GLP-1 agonists than sulfonylureas, a recent analysis of a VA database finds Does Mounjaro cause pancreatitis? |
Description
Love Manny and the staff

Tirzepatide clinical trials demonstrate measurable weight loss beginning around 4-8 weeks for most participants, with average reductions of 15-22% body weight over 68 weeks at therapeutic doses
, Benadda, S

Original YFAS scores decreased from 2.24 at baseline to 1.93 post-treatment, only 13.8%

One study reports that over the course of 40 weeks, people taking 1 mg weekly of Ozempic lost an average of 13 pounds

Obesity can significantly increase the risk of various diseases, such as cardiovascular and cerebrovascular, endocrine, specific tumors, respiratory, reproductive, and skeletal diseases, and can seriously affect quality of life [1]
